Trial Profile
Comparison of the Efficacy and Safety of High Dose Monotherapy and Low Dose Combination of Telmisartan and/or Amlodipine in Inadequately Controlled Hypertensive Patients taking Low Dose Monotherapy of Either Drug- A Single Center, Open Label, Three-Arm, Randomized, Parallel Group, Prospective Study.
Status:
Not yet recruiting
Phase of Trial:
Phase III
Latest Information Update: 05 Mar 2018
Price :
$35
*
At a glance
- Drugs Amlodipine (Primary) ; Telmisartan (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- 29 Sep 2013 New trial record